Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic implications of autoimmune vitiligo T cells.
Oyarbide-Valencia K, van den Boorn JG, Denman CJ, Li M, Carlson JM, Hernandez C, Nishimura MI, Das PK, Luiten RM, Le Poole IC. Oyarbide-Valencia K, et al. Among authors: van den boorn jg. Autoimmun Rev. 2006 Aug;5(7):486-92. doi: 10.1016/j.autrev.2006.03.012. Epub 2006 May 6. Autoimmun Rev. 2006. PMID: 16920575 Free PMC article. Review.
Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy.
van den Boorn JG, Picavet DI, van Swieten PF, van Veen HA, Konijnenberg D, van Veelen PA, van Capel T, Jong EC, Reits EA, Drijfhout JW, Bos JD, Melief CJ, Luiten RM. van den Boorn JG, et al. Among authors: van veen ha, van capel t, van veelen pa, van swieten pf. J Invest Dermatol. 2011 Jun;131(6):1240-51. doi: 10.1038/jid.2011.16. Epub 2011 Feb 17. J Invest Dermatol. 2011. PMID: 21326294 Free article.
Inflammasome-Dependent Induction of Adaptive NK Cell Memory.
van den Boorn JG, Jakobs C, Hagen C, Renn M, Luiten RM, Melief CJ, Tüting T, Garbi N, Hartmann G, Hornung V. van den Boorn JG, et al. Immunity. 2016 Jun 21;44(6):1406-21. doi: 10.1016/j.immuni.2016.05.008. Epub 2016 Jun 7. Immunity. 2016. PMID: 27287410 Free article.
RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation.
Engel C, Brügmann G, Lambing S, Mühlenbeck LH, Marx S, Hagen C, Horváth D, Goldeck M, Ludwig J, Herzner AM, Drijfhout JW, Wenzel D, Coch C, Tüting T, Schlee M, Hornung V, Hartmann G, Van den Boorn JG. Engel C, et al. Among authors: van den boorn jg. Cancer Immunol Res. 2017 Jun;5(6):455-467. doi: 10.1158/2326-6066.CIR-16-0129-T. Epub 2017 May 3. Cancer Immunol Res. 2017. PMID: 28468914
RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma.
Lambing S, Tan YP, Vasileiadou P, Holdenrieder S, Müller P, Hagen C, Garbe S, Behrendt R, Schlee M, van den Boorn JG, Bartok E, Renn M, Hartmann G. Lambing S, et al. Among authors: van den boorn jg. J Mol Cell Biol. 2023 Jun 1;15(1):mjad001. doi: 10.1093/jmcb/mjad001. J Mol Cell Biol. 2023. PMID: 36626927 Free PMC article.
17 results